Francesca Sperotto1, Giorgio Cuffaro1, Sara Brachi1, Mara Seguso1, Francesco Zulian2. 1. From the Department of Pediatrics, University of Padua, Padua, Italy.F. Sperotto, MD, Pediatric Rheumatology Fellow; G. Cuffaro, MD, Pediatric Rheumatology Fellow; S. Brachi, MD, Pediatric Rheumatology Fellow; M. Seguso, MD, Assistant Professor, Laboratory Medicine; F. Zulian, MD, Assistant Professor, Rheumatology Unit, Department of Pediatrics, University of Padua. 2. From the Department of Pediatrics, University of Padua, Padua, Italy.F. Sperotto, MD, Pediatric Rheumatology Fellow; G. Cuffaro, MD, Pediatric Rheumatology Fellow; S. Brachi, MD, Pediatric Rheumatology Fellow; M. Seguso, MD, Assistant Professor, Laboratory Medicine; F. Zulian, MD, Assistant Professor, Rheumatology Unit, Department of Pediatrics, University of Padua. zulian@pediatria.unipd.it.
Abstract
OBJECTIVE: The role of antinuclear antibodies (ANA) in children has still to be elucidated. The aim of our study was to evaluate the prevalence and persistence of ANA in schoolchildren during the puberty switch, and the possible relationship with chronic noninflammatory musculoskeletal pain (MSP). METHODS: Children aged 8-13 years and attending 4 public schools underwent a clinical examination, focusing on pubertal stage and presence of chronic noninflammatory MSP. Laboratory tests to determine the autoantibody-profile were also performed. Subjects with ANA positivity (titer ≥ 1:80) and/or chronic noninflammatory MSP were re-evaluated 3 years later. RESULTS: Two hundred sixty-one subjects enrolled in the study and 12.3% were ANA-positive, equally distributed in terms of sex and pubertal status. Three years later, in the group of patients studied for chronic noninflammatory MSP (n = 67), ANA positivity significantly increased from 13.4% to 44.8%. In the ANA-positive cohort at baseline (n = 28), 92.9% of subjects were confirmed as being ANA-positive with a significantly increased titer. No association between ANA positivity and chronic noninflammatory MSP was found. CONCLUSION: ANA prevalence and titers increase during puberty, especially in females, but have no relationship with chronic noninflammatory MSP. This finding may be related to the complex hormonal changes during the puberty switch period and opens new insights into autoimmunity.
OBJECTIVE: The role of antinuclear antibodies (ANA) in children has still to be elucidated. The aim of our study was to evaluate the prevalence and persistence of ANA in schoolchildren during the puberty switch, and the possible relationship with chronic noninflammatory musculoskeletal pain (MSP). METHODS:Children aged 8-13 years and attending 4 public schools underwent a clinical examination, focusing on pubertal stage and presence of chronic noninflammatory MSP. Laboratory tests to determine the autoantibody-profile were also performed. Subjects with ANA positivity (titer ≥ 1:80) and/or chronic noninflammatory MSP were re-evaluated 3 years later. RESULTS: Two hundred sixty-one subjects enrolled in the study and 12.3% were ANA-positive, equally distributed in terms of sex and pubertal status. Three years later, in the group of patients studied for chronic noninflammatory MSP (n = 67), ANA positivity significantly increased from 13.4% to 44.8%. In the ANA-positive cohort at baseline (n = 28), 92.9% of subjects were confirmed as being ANA-positive with a significantly increased titer. No association between ANA positivity and chronic noninflammatory MSP was found. CONCLUSION: ANA prevalence and titers increase during puberty, especially in females, but have no relationship with chronic noninflammatory MSP. This finding may be related to the complex hormonal changes during the puberty switch period and opens new insights into autoimmunity.
Authors: Wilton Ferreira Silva Santos; Ana Paula de Castro Cantuária; Daniele de Castro Félix; Leandro Kegler Nardes; Igor Cabral Santos de Melo Journal: Adv Rheumatol Date: 2022-08-15
Authors: Emily C Somers; Seetha U Monrad; Jeffrey S Warren; Maritsa Solano; Lourdes Schnaas; Mauricio Hernandez-Avila; Martha Maria Tellez-Rojo; Howard Hu Journal: Clin Epidemiol Date: 2016-12-20 Impact factor: 4.790
Authors: Victoria K Tesch; Hanna IJspeert; Andrea Raicht; Daniel Rueda; Nerea Dominguez-Pinilla; Luis M Allende; Chrystelle Colas; Thorsten Rosenbaum; Denisa Ilencikova; Hagit N Baris; Michaela H M Nathrath; Manon Suerink; Danuta Januszkiewicz-Lewandowska; Iman Ragab; Amedeo A Azizi; Soeren S Wenzel; Johannes Zschocke; Wolfgang Schwinger; Matthias Kloor; Claudia Blattmann; Laurence Brugieres; Mirjam van der Burg; Katharina Wimmer; Markus G Seidel Journal: Front Immunol Date: 2018-07-02 Impact factor: 7.561
Authors: Nina M de Gruijter; Meena Naja; Hannah Peckham; Anna Radziszewska; Matthew Kinsella; James Glenister; Elizabeth C Rosser; Gary E Butler; Elizabeth C Jury; Coziana Ciurtin Journal: Pediatr Rheumatol Online J Date: 2021-03-29 Impact factor: 3.054
Authors: Gregg E Dinse; Christine G Parks; Clarice R Weinberg; Caroll A Co; Jesse Wilkerson; Darryl C Zeldin; Edward K L Chan; Frederick W Miller Journal: Arthritis Rheumatol Date: 2020-04-30 Impact factor: 15.483